Works matching DE "INSULIN pharmacokinetics"


Results: 120
    1

    Beware the pitfalls of time below range.

    Published in:
    Diabetic Medicine, 2023, v. 40, n. 11, p. 1, doi. 10.1111/dme.15124
    By:
    • Thabit, Hood;
    • Schofield, Jonathan;
    • Leelarathna, Lalantha
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

    Published in:
    2000
    By:
    • Lepore, Mauro;
    • Fanelli, Carmine;
    • Porcellati, Francesca;
    • Bartocci, Linda;
    • Di Vincenzo, Antonio;
    • Cordoni, Cristina;
    • Costa, Emanuela;
    • Brunetti, Paolo;
    • Bolli, Geremia B.;
    • Lepore, M;
    • Pampanelli, S;
    • Fanelli, C;
    • Porcellati, F;
    • Bartocci, L;
    • Di Vincenzo, A;
    • Cordoni, C;
    • Costa, E;
    • Brunetti, P;
    • Bolli, G B
    Publication type:
    journal article
    16
    17

    Free fatty acids impair hepatic insulin extraction in vivo.

    Published in:
    1999
    By:
    • Wiesenthal, Stephanie R.;
    • Sandhu, Harmanjit;
    • McCall, Richard H.;
    • Tchipashvili, Vaja;
    • Yoshii, Hidenori;
    • Polonsky, Kenneth;
    • Shi, Zed Q.;
    • Lewis, Gary F.;
    • Mari, Andrea;
    • Giacca, Adria;
    • Wiesenthal, S R;
    • Sandhu, H;
    • McCall, R H;
    • Tchipashvili, V;
    • Yoshii, H;
    • Polonsky, K;
    • Shi, Z Q;
    • Lewis, G F;
    • Mari, A;
    • Giacca, A
    Publication type:
    journal article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN<sup>®</sup> Basal-Bolus Type 1): 2-year results of a randomized clinical trial

    Published in:
    Diabetic Medicine, 2013, v. 30, n. 11, p. 1293, doi. 10.1111/dme.12243
    By:
    • Bode, B. W.;
    • Buse, J. B.;
    • Fisher, M.;
    • Garg, S. K.;
    • Marre, M.;
    • Merker, L.;
    • Renard, E.;
    • Russell‐Jones, D. L.;
    • Hansen, C. T.;
    • Rana, A.;
    • Heller, S. R.
    Publication type:
    Article
    45
    46
    47
    48
    49
    50